HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models-Reference-Cited by-同舟云学术

HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models

Published:2014-07-17 Issue:16 Volume:5 Page:7138-7148
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Thomas Gaëlle¹²,Chardès Thierry¹,Gaborit Nadège¹,Mollevi Caroline³,Leconet Wilhem¹,Robert Bruno¹,Radosevic-Robin Nina⁴,Penault-Llorca Frédérique⁴,Gongora Céline¹,Colombo Pierre-Emmanuel¹,Lazrek Yassamine¹⁵,Bras-Goncalves Rui¹,Savina Ariel⁶,Azria David¹,Bazin Hervé⁷,Pèlegrin André¹,Larbouret Christel¹

Affiliation:

1. IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, F-34298, France; INSERM, Unit 896, Montpellier, F-34298, France; Université Montpellier1, Montpellier, F-34298, France; ICM, Montpellier, France

2. Institut Roche de Recherche et Médecine Translationnelle, Boulogne Bilancourt, France

3. Unité de Biostatistiques, ICM Val d'Aurelle, Montpellier, France

4. Department of Biopathology, The Jean Perrin Comprehensive Cancer Center and ERTICa Research Group, University of Auvergne EA4677, Clermont-Ferrand, France

5. Millegen SA, F-31681, Labège, France

6. Roche SAS Scientific Partnerships, Boulogne Billancourt, France

7. CisBio Bioassays, Le Codolet, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer;Frontiers in Oncology;2024-07-17

2. HER3 (ERBB3) amplification in liposarcoma - a putative new therapeutic target?;World Journal of Surgical Oncology;2024-05-17

3. Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma;Oncogenesis;2023-11-10

4. Adenovirus-Derived Nano-Capsid Platforms for Targeted Delivery and Penetration of Macromolecules into Resistant and Metastatic Tumors;Cancers;2023-06-19

5. Targeting the EGFR signaling pathway in cancer therapy: What’s new in 2023?;Expert Opinion on Therapeutic Targets;2023-05-04